The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of preoperative modified FOLFIRINOX (mFOLFIRINOX) followed by postoperative gemcitabine (GEM) in patients (pts) with borderline resectable pancreatic ductal adenocarcinomas (BR-PDAC).
 
Changhoon Yoo
Honoraria - Bayer; Ipsen
Consulting or Advisory Role - LSK BioPharma
Speakers' Bureau - Bayer; Celgene; Ipsen
 
Kyu-Pyo Kim
Travel, Accommodations, Expenses - Agios; Roche/Genentech; Roche/Genentech
 
Ki Byung Song
No Relationships to Disclose
 
Sang Soo Lee
No Relationships to Disclose
 
Do Hyun Park
No Relationships to Disclose
 
Tae Jun Song
No Relationships to Disclose
 
Seung Soo Lee
No Relationships to Disclose
 
Jin-hong Park
No Relationships to Disclose
 
Dae Wook Hwang
No Relationships to Disclose
 
Jae Hoon Lee
No Relationships to Disclose
 
Sang Hyun Shin
No Relationships to Disclose
 
Eunseon Shin
No Relationships to Disclose
 
Baek-Yeol Ryoo
No Relationships to Disclose
 
Song Cheol Kim
No Relationships to Disclose